Guen-Woo Jin

Title: Guen-Woo Jin: Innovator in Drug-Organic-Acid-Anhydride Conjugates

Introduction

Guen-Woo Jin is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of drug-organic-acid-anhydride conjugates. His innovative approach has the potential to enhance drug delivery systems and improve therapeutic outcomes.

Latest Patents

Guen-Woo Jin holds a patent for "Synthesizing drug-organic-acid-anhydride conjugates without using coupling reagent." This patent details a method for synthesizing a drug-organic-acid-anhydride conjugate using docetaxel as a drug. The process involves several steps, including mixing aconitic anhydride with a chlorinating reagent, dissolving the mixture in an organic solvent, stirring, evaporating the solvent, washing the resulting mixture, and finally mixing docetaxel with the aconitic anhydride chloride solution to produce the desired conjugate. This innovative method streamlines the synthesis process and eliminates the need for coupling reagents.

Career Highlights

Guen-Woo Jin is currently associated with Cnpharm Co. Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its potential applications in the pharmaceutical industry, particularly in improving drug efficacy and safety.

Collaborations

Guen-Woo Jin collaborates with notable colleagues, including Hojun Kim and Kwang Sik Park. Their combined expertise contributes to the innovative research environment at Cnpharm Co. Ltd.

Conclusion

Guen-Woo Jin's contributions to the field of drug synthesis exemplify the importance of innovation in pharmaceuticals. His patented methods pave the way for advancements in drug delivery systems, showcasing the potential for improved therapeutic solutions.